DavidGandaraMD

PubMed

• CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Tran...
  Ebaa Al-Obeidi, Karen Kelly, David R Gandara, Jonathan W Riess> ;JCO Precision Oncology. 2024 Apr 1
• Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations.
  Daniel L Hertz, Markus Joerger, Yung-Jue Bang, Ron H Mathijssen, Caicun Zhou, Li Zhang, Michael Stahl, Bradley J Monk, Ulrich Jaehde, Jan H Beumer, David Gandara> ;European Journal of Cancer. 2024 Mar 19
• Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer.
  Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Re...> ;JCO Precision Oncology. 2024 Mar 1
• Mapping EGFR Exon 20 Resistance Mutations: An Intricate Landscape.
  Singhal, S., Gandara, D., Riess, J.> ;Journal of Thoracic Oncology. 2024 Jan 1
• Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
  Wang, K., Du, R., Myall, N., Lewis, W., Uy, N., Hong, L., Skoulidis, F., Byers, L., Tsao, A., Cascone, T., Pozadzides, J., Tu, J., Negrao, M., Gibbons, D., Park, K., R...> ;Journal of Thoracic Oncology. 2024 Mar 1
• Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes.
  Pashtoon Murtaza Kasi, Leslie A Bucheit, Jiemin Liao, Jason Starr, Pedro Barata, Samuel J Klempner, David Gandara, Ardaman Shergill, Luciana Madeira da Silva, Caroline...> ;JCO Precision Oncology. 2023 Sep 1
• Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).
  Riha Vaidya, Joseph M Unger, Lu Qian, Katherine Minichiello, Roy S Herbst, David R Gandara, Joel W Neal, Ticiana A Leal, Jyoti D Patel, Konstantin H Dragnev, Saiama N ...> ;JCO Precision Oncology. 2023 Sep 1
• 1 citations
  Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).
  Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, N...> ;Clinical Cancer Research. 2023 Sep 15
• Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.
  Giorgio Vittorio Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, Ulrich Gatzemeier, Raghunadha...> ;Journal of Clinical Oncology. 2023 May 10
• 4 citations
  Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer.
  Ebaa Al-Obeidi, Jonathan W Riess, Umberto Malapelle, Christian Rolfo, David R Gandara> ;Hematology/oncology Clinics of North America. 2023 Jun 1
• 2 citations
  27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study.
  David L Saltman, Matthew G Varga, Tyler J Nielsen, Nicole S Croteau, Heather M Lockyer, Amit L Jain, Gregory A Vidal, David R Hout, Brock L Schweitzer, Robert S Seitz,...> ;Clinical Lung Cancer. 2023 Mar 1
• 2 citations
  Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
  Joseph M Unger, Lu Qian, Mary W Redman, Susan S Tavernier, Lori Minasian, Ellen V Sigal, Vassiliki A Papadimitrakopoulou, Michael Leblanc, Charles S Cleeland, Samuel A...> ;Journal of the National Cancer Institute. 2023 Apr 11
• 1 citations
  Phase 1 Study of Ceritinib Combined With Trametinib in Patients With Advanced ALK- or ROS1-Positive NSCLC.
  Matthew S Lara, Matthew A Gubens, Bianca Bacaltos, Lea Daran, Steffany L Lim, Tianhong Li, David R Gandara, Trever G Bivona, Jonathan W Riess, Collin M Blakely> ;JTO Clinical and Research Reports. 2022 Dec 1
• 2 citations
  A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer.
  Xing Yi Woo, Anuj Srivastava, Philip C Mack, Joel H Graber, Brian J Sanderson, Michael W Lloyd, Mandy Chen, Sergii Domanskyi, Regina Gandour-Edwards, Rebekah A Tsai, J...> ;Cancer Research. 2022 Nov 15
• 42 citations
  Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 t...
  Solange Peters, Rafal Dziadziuszko, Alessandro Morabito, Enriqueta Felip, Shirish M Gadgeel, Parneet Cheema, Manuel Cobo, Zoran Andric, Carlos H Barrios, Masafumi Yama...> ;Nature Medicine. 2022 Sep 1
• 12 citations
  Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403).
  Philip C Mack, Jieling Miao, Mary W Redman, James Moon, Sarah B Goldberg, Roy S Herbst, Mary Ann Melnick, Zenta Walther, Fred R Hirsch, Katerina Politi, Karen Kelly, D...> ;Clinical Cancer Research. 2022 Sep 1
• 4 citations
  A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
  Justin A Chen, Jasmine C Huynh, Chun-Yi Wu, Ai-Ming Yu, Karen Matsukuma, Thomas J Semrad, David R Gandara, Tianhong Li, Jonathan W Riess, Kit Tam, Philip C Mack, Antho...> ;Cancer Chemotherapy and Pharmacology. 2022 Sep 1
• 3 citations
  Prevalence ofMutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations.
  Razelle Kurzrock, Charu Aggarwal, Caroline Weipert, Lesli Kiedrowski, Jonathan Riess, Heinz-Josef Lenz, David Gandara> ;Cancers. 2022 Sep 1
• 12 citations
  The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations.
  Christian Caglevic, Christian Rolfo, Ignacio Gil-Bazo, Andrés Cardona, Jorge Sapunar, Fred R Hirsch, David R Gandara, Gilberto Morgan, Silvia Novello, Marina-Chiara Ga...> ;JCO Global Oncology. 2022 Aug 1
• 62 citations
  Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MA...
  Karen L Reckamp, Mary W Redman, Konstantin H Dragnev, Katherine Minichiello, Liza C Villaruz, Bryan Faller, Tareq Al Baghdadi, Susan Hines, Leah Everhart, Louise Highl...> ;Journal of Clinical Oncology. 2022 Jul 20
• 7 citations
  Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer.
  Harsha Ranganath, Amit L Jain, Justin R Smith, Julie Ryder, Amina Chaudry, Emily Miller, Felicia Hare, Poojitha Valasareddy, Robert S Seitz, David R Hout, Matthew G Va...> ;BMC Cancer. 2022 Apr 14
• 14 citations
  Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer.
  Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo, Oscar Arrieta, Beatriz Bellosillo, Andrés F. Cardona, Massimo Cristofanilli, Diego de Miguel-Pérez, Valeria Denning...> ;Expert Review of Molecular Diagnostics. 2021 Oct 11
• 5 citations
  EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG...
  Fred R. Hirsch, Mary W. Redman, James Moon, Francesco Agustoni, Roy S. Herbst, Thomas J. Semrad, Marileila Varella-Garcia, Christopher J. Rivard, Karen Kelly, David R....> ;Clinical Lung Cancer. 2021 Oct 10
• 150 citations
  Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
  Christian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlesi, Trever G. Bivona, Maximilian Diehn, Caroline Dive, Rafal Dzia...> ;Journal of Thoracic Oncology. 2021 Oct 1
• 17 citations
  NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
  Christian Rolfo, Alexander Drilon, David S. Hong, Caroline E. McCoach, Afshin Dowlati, Jessica J. Lin, Alessandro Russo, Alison M. Schram, Stephen V. Liu, Jorge Nieva,...> ;British Journal of Cancer. 2021 Sep 3
• Join now to see all